First Trust Advisors
CYTK icon

First Trust Advisors’s Cytokinetics CYTK Stock Holding History

First Trust Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Sell
118,149
-27,741
-19% -$1.99M 0.01% 1215
2026
Q1 		$9.62M Buy
145,890
+18,366
+14% +$1.17M 0.01% 1110
2025
Q4 		$8.1M Buy
+127,524
New +$7.93M 0.01% 1183
2024
Q4 		– Sell
-12,039
Closed -$636K – 2577
2024
Q3 		$636K Sell
12,039
-9,350
-44% -$521K ﹤0.01% 2115
2024
Q2 		$1.16M Sell
21,389
-16,560
-44% -$1,000K ﹤0.01% 1911
2024
Q1 		$2.66M Buy
+37,949
New +$2.94M ﹤0.01% 1610
2023
Q2 		– Sell
-58,292
Closed -$2.05M – 2369
2023
Q1 		$2.05M Sell
58,292
-50,019
-46% -$2.04M ﹤0.01% 1682
2022
Q4 		$4.96M Buy
108,311
+41,947
+63% +$1.8M 0.01% 1199
2022
Q3 		$3.21M Buy
66,364
+31,485
+90% +$1.52M ﹤0.01% 1417
2022
Q2 		$1.37M Sell
34,879
-32,123
-48% -$1.29M ﹤0.01% 1864
2022
Q1 		$2.47M Sell
67,002
-87,077
-57% -$3.09M ﹤0.01% 1698
2021
Q4 		$7.02M Buy
+154,079
New +$5.95M 0.01% 1207
2021
Q3 		– Sell
-75,858
Closed -$1.5M – 2539
2021
Q2 		$1.5M Buy
75,858
+26,570
+54% +$624K ﹤0.01% 1917
2021
Q1 		$1.15M Buy
49,288
+10,583
+27% +$226K ﹤0.01% 1944
2020
Q4 		$804K Buy
+38,705
New +$707K ﹤0.01% 1981

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors's CYTK Position: Q2 2026 in Review

First Trust Advisors reduced its Cytokinetics (CYTK) stake by 19% in Q2 2026, selling an estimated $1.99M and leaving 118,149 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #1215.

First Trust Advisors first reported a position in CYTK in Q4 2020 and has held it in 15 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • First Trust Advisors held 118,149 shares of Cytokinetics worth $10.1M as of Q2 2026.
  • First Trust Advisors sold 27,741 Cytokinetics shares in Q2 2026, an estimated $1.99M.
  • Cytokinetics made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1215 holding.
  • First Trust Advisors first reported a position in Cytokinetics in Q4 2020 and has held it in 15 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.